Potential association between the gut microbiome and inflammatory and metabolic pathways in the cardiovascular system is examined in a new clinical study called GutHeart Trial.

‘New innovative treatment strategies can lead to a better knowledge of how gut leakage is linked with inflammatory processes and heart failure.’

"To the best of our knowledge, the GutHeart trial is the first intervention study to assess the profile of the gut microbiota in heart failure patients and the way this profile is affected by drugs that act locally in the gut," said first author Dr. Cristiane C. K. Mayerhofer, of Oslo University Hospital, in Norway.




"The new knowledge can pave the way for new innovative treatment strategies and will lead to a better understanding of how gut leakage is associated with inflammatory processes and heart failure."
The potential significance of the study extends beyond the cardiovascular system, noted co-author Dr. Ayodeji Awoyemi, of Oslo University Hospital Ulleval. "It will most definitely expand our knowledge about the clinical implications of modulating the gut microbiome," he said.
Source-Eurekalert